Adverse effects of atypical antipsychotics: differential risk and clinical implications
PM Haddad, SG Sharma - CNS drugs, 2007 - Springer
Antipsychotic drugs can be of great benefit in a range of psychiatric disorders, including
schizophrenia and bipolar disorder, but all are associated with a wide range of potential …
schizophrenia and bipolar disorder, but all are associated with a wide range of potential …
Neurological complications of psychiatric drugs: clinical features and management
PM Haddad, SM Dursun - … Psychopharmacology: Clinical and …, 2008 - Wiley Online Library
This paper reviews the main neurological complications of psychiatric drugs, in particular
antipsychotics and antidepressants. Extrapyramidal syndromes include acute dystonia …
antipsychotics and antidepressants. Extrapyramidal syndromes include acute dystonia …
The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia
VI Reus, LJ Fochtmann, AE Eyler… - American Journal of …, 2016 - Am Psychiatric Assoc
The goal of this guideline is to improve the care of patients with dementia who are exhibiting
agitation or psychosis. More specifically, this guideline focuses on the judicious use of …
agitation or psychosis. More specifically, this guideline focuses on the judicious use of …
[PDF][PDF] The use of antipsychotic medication for people with dementia: time for action
S Banerjee - 2009 - psychrights.org
Examining the literature, there is a clear emerging consensus about the positive and
negative effects of antipsychotic drugs. This review has benefited from being able to access …
negative effects of antipsychotic drugs. This review has benefited from being able to access …
Antipsychotic drug use and mortality in older adults with dementia
SS Gill, SE Bronskill, SLT Normand… - Annals of internal …, 2007 - acpjournals.org
Background: Antipsychotic drugs are widely used to manage behavioral and psychological
symptoms in dementia despite concerns about their safety. Objective: To examine the …
symptoms in dementia despite concerns about their safety. Objective: To examine the …
Lipoprotein (a) levels and risk of future coronary heart disease: large-scale prospective data
A Bennet, E Di Angelantonio, S Erqou… - Archives of internal …, 2008 - jamanetwork.com
Background Large-scale prospective data are needed to determine whether associations
between lipoprotein (a)(Lp [a]) and coronary heart disease (CHD) risk are independent of …
between lipoprotein (a)(Lp [a]) and coronary heart disease (CHD) risk are independent of …
Atypical antipsychotic use in patients with dementia: managing safety concerns
M Steinberg, CG Lyketsos - American Journal of Psychiatry, 2012 - Am Psychiatric Assoc
Neuropsychiatric symptoms such as agitation and delusions occur commonly in elderly
patients with dementia and often cause significant distress. Data on treatment efficacy are …
patients with dementia and often cause significant distress. Data on treatment efficacy are …
Antipsychotic therapy and short-term serious events in older adults with dementia
Background Antipsychotic therapy is widely used to treat behavioral problems in older adults
with dementia. Cohort studies evaluating the safety of antipsychotic therapy generally focus …
with dementia. Cohort studies evaluating the safety of antipsychotic therapy generally focus …
Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence
V Mittal, L Kurup, D Williamson… - American Journal of …, 2011 - journals.sagepub.com
Behavioral and Psychological Symptoms of Dementia (BPSD) are increasingly recognized
as a major risk factor for caregiver burden, institutionalization, greater impairment in …
as a major risk factor for caregiver burden, institutionalization, greater impairment in …
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease
N Herrmann, S Gauthier - Cmaj, 2008 - Can Med Assoc
Background: The management of severe Alzheimer disease often presents difficult choices
for clinicians and families. The disease is characterized by a need for full-time care and …
for clinicians and families. The disease is characterized by a need for full-time care and …